Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents

Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents

Objective. To identify the frequency of obesity and metabolic complications in child and adolescent users of risperidone. Potential associations with clinical parameters and SNPs of the HTR2C, DRD2, LEP, LEPR, MC4R, and CYP2D6 genes were analyzed. Methods. Samples from 120 risperidone users (8–20 ye...

Full description

Saved in:

Bibliographic Details
Main Authors:	Amilton Dos Santos-Júnior, Taciane Barbosa Henriques, Maricilda Palandi de Mello, Osmar Henrique Della Torre, Lúcia Arisaka Paes, Adriana Perez Ferreira-Neto, Letícia Esposito Sewaybricker, Thiago Salum Fontana, Eloisa Helena Rubello Valler Celeri, Gil Guerra-Júnior, Paulo Dalgalarrondo
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2016/5872423
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacogenetics of Oral Antidiabetic Drugs
by: Matthijs L. Becker, et al.
Published: (2013-01-01)

Editorial: Pharmacogenetics of psychiatric disorders
by: Sarah Allegra, et al.
Published: (2025-01-01)

Pharmacogenetics of Chronic Pain and Its Treatment
by: Svatopluk Světlík, et al.
Published: (2013-01-01)

Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023
by: José A. G. Agúndez, et al.
Published: (2025-01-01)

Clinical and Laboratorial Features That May Differentiate 46,XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency
by: Nélio Neves Veiga-Junior, et al.
Published: (2012-01-01)

Risperidone oral disintegrating mini-tablets: A robust-product for pediatrics
by: El-Say Khalid M., et al.
Published: (2015-12-01)

Stability Indicating HPLC Determination of Risperidone in Bulk Drug and Pharmaceutical Formulations
by: Zarna R. Dedania, et al.
Published: (2011-01-01)

A case of vocal tics presented as chronic cough treated with risperidone
by: Dhruvasan Saritha, et al.
Published: (2023-05-01)

Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia, presenting as spurious pancytopenia, associated with risperidone
by: Harkishan Mamtani, et al.
Published: (2023-03-01)

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Arwa M. Amin, et al.
Published: (2017-01-01)

Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals
by: Jacinta Nwamaka Nwogu, et al.
Published: (2016-01-01)

Preparation and in vivo evaluation of a gel-based nasal delivery system for risperidone
by: Gu Fugen, et al.
Published: (2016-12-01)

Activation of osteoblast ferroptosis by risperidone accelerates bone loss in mice models of schizophrenia
by: Hongyan Fan, et al.
Published: (2025-01-01)

Optimizing Antipsychotic Therapy in Acute Alcoholic Hallucinosis through Pharmacogenetic Testing
by: Valentin Skryabin, et al.
Published: (2024-12-01)

Pharmacogenetic and pharmacokinetic factors for dexmedetomidine-associated hemodynamic instability in pediatric patients
by: Yanping Guan, et al.
Published: (2025-01-01)

Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
by: Defa Huang, et al.
Published: (2024-12-01)

Neuropsychiatric symptoms and specific cognitive domains in mild cognitive impairment
by: Lucas Luchesi Barnes, et al.
Published: (2025-01-01)

Risperidone-Induced Neutropenia in a Schizophrenic Patient: A Case Report and Literature Review
by: Ayodele Atolagbe, et al.
Published: (2021-01-01)

Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers
by: Andrea Rodríguez-Lopez, et al.
Published: (2024-12-01)

To be or not to be, when synthetic data meet clinical pharmacology: A focused study on pharmacogenetics
by: Jean‐Baptiste Woillard, et al.
Published: (2025-01-01)

Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol
by: Sergi Mas, et al.
Published: (2025-01-01)

Long-Term Follow-Up of Patients with 46,XY Partial Gonadal Dysgenesis Reared as Males
by: Juliana Gabriel Ribeiro de Andrade, et al.
Published: (2014-01-01)

Integrating pharmacogenetics, multi‐omics and machine learning in the novel therapeutic view of pulmonary hypertension
by: Chenxi Li, et al.
Published: (2025-01-01)

Pharmacogenetic markers of colorectal cancer treatment. New approaches for cytostatic drugs efficacy estimation
by: N. B. Zakharzhevskaya, et al.
Published: (2015-12-01)

Advanced LC-MS/MS method for selective quantification of nitrosamine impurities in Risperidone: Enhancing drug safety
by: Hitesh Thumbar, et al.
Published: (2025-08-01)

First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone
by: Aaron J. Roberto, et al.
Published: (2016-01-01)

Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial
by: Paul Bassett, et al.
Published: (2020-09-01)

Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
by: Muriel Javier, et al.
Published: (2023-06-01)

Assessing the Roles of Molecular Markers of Antimalarial Drug Resistance and the Host Pharmacogenetics in Drug-Resistant Malaria
by: Peter Hodoameda, et al.
Published: (2022-01-01)

A case report of exacerbation of extrapyramidal symptoms following the switch from risperidone to paliperidone during valproate therapy
by: Emi Hata, et al.
Published: (2025-01-01)

Pharmacogenetics: Influence of CYP2C9*2 and *3 alleles polymorphisms on Iraqi type 2 diabetic patients
by: Ghada S. Rasool, et al.
Published: (2024-01-01)

Comparative effect of atorvastatin and risperidone on modulation of TLR4/NF-κB/NOX-2 in a rat model of valproic acid-induced autism
by: Eman A. E. Farrag, et al.
Published: (2024-09-01)

Souvenirs rétrospectifs de l’Anthropocène : la ville dans la cli‑fi italienne
by: Lucia Della Fontana
Published: (2023-12-01)

Serum IL-1β, sIL-2R, IL-6, IL-8 and TNF-α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment
by: Ayşe Binnur Erbağci, et al.
Published: (2001-01-01)

Functional and Structural Consequences of Nine CYP21A2 Mutations Ranging from Very Mild to Severe Effects
by: Débora de Paula Michelatto, et al.
Published: (2016-01-01)

Taking the Evolution of the Standards of Proof for a Criminal Conviction Seriously
by: Jacopo Della Torre
Published: (2025-01-01)

reconhecimento da identidade cultural indígena e a proteção dos direitos da personalidade
by: Beatriz Caroline Fiaes, et al.
Published: (2021-12-01)

Mapeamento da população em situação de rua na cidade do Rio de Janeiro: uma proposta metodológica
by: João Grand Junior, et al.
Published: (2022-06-01)

Riforma Cartabia e digitalizzazione della giustizia penale
by: Jacopo Della Torre, et al.
Published: (2024-12-01)

“PARA AFIANZAR ESA LIBERTAD TAN DESEADA, NO BASTA SOLO LA MUERTE DE BOLÍVAR”: ANTIBOLIVARISMO E O DILEMA CONSTITUCIONAL VENEZUELANO DE 1830
by: Matheus Amilton Martins
Published: (2025-01-01)